Patritumab
Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
Product Specifications
CAS Number
1262787-83-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
ERK | EGFR | HER | Akt
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
134244-FITC 100 µL
TBCC (Tubulin-specific Chaperone C, Tubulin-folding Cofactor C, CFC) (FITC)
Ask
View Details